Mechanistic insights of soluble uric acid-induced insulin resistance: Insulin signaling and beyond.

Abstract

Hyperuricemia is a metabolic disease caused by purine nucleotide metabolism disorder. The prevalence of hyperuricemia is increasing worldwide, with a growing trend in the younger populations. Although numerous studies have indicated that hyperuricemia may be an independent risk factor for insulin resistance, the causal relationship between the two is controversial. There are few reviews, however, focusing on the relationship between uric acid (UA) and insulin resistance from experimental studies. In this review, we summarized the experimental models related to soluble UA-induced insulin resistance in pancreas and peripheral tissues, including skeletal muscles, adipose tissue, liver, heart/cardiomyocytes, vascular endothelial cells and macrophages. In addition, we summarized the research advances about the key mechanism of UA-induced insulin resistance. Moreover, we attempt to identify novel targets for the treatment of hyperuricemia-related insulin resistance. Lastly, we hope that the present review will encourage further researches to solve the chicken-and-egg dilemma between UA and insulin resistance, and provide strategies for the pathogenesis and treatment of hyperuricemia related metabolic diseases.

• Authors: Wei Yu, De Xie, Tetsuya Yamamoto, Hidenori Koyama, Jidong Cheng
• Journal: Reviews in endocrine & metabolic disorders (Rev Endocr Metab Disord) Vol. 24 Issue 2 Pg. 327-343 (04 2023) ISSN: 1573-2606 [Electronic] Germany
• PMID: 36715824 (Publication Type: Journal Article, Review, Research Support, Non-U.S. Gov't)
• Copyright: © 2023. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Chemical References

• Uric Acid
• Insulin

Topics

• Humans
• Insulin Resistance
• Uric Acid (metabolism)
• Insulin
• Hyperuricemia (metabolism)
• Endothelial Cells (metabolism)